Advertisement
Advertisement

AEON

AEON logo

AEON Biopharma, Inc.

0.90
USD
Sponsored
-0.01
-1.10%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

0.91

+0.01
+1.11%

AEON Biopharma, Inc. Profile

About

AEON Biopharma Inc. is a clinical-stage biopharmaceutical company. It focused on developing a proprietary botulinum toxin complex for the treatment of multiple debilitating medical conditions. AEON Biopharma Inc., formerly known as Priveterra Acquisition Corp., is based in IRVINE, Calif.

Info & Links

CEO

Robert Bancroft

Headquarters

5 PARK PLAZA, SUITE 1750
IRVINE, CA 92614, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.aeonbiopharma.com

Auditor

KPMG LLP

Share holders

464

Employees

8

AEON Biopharma, Inc. Statistics

Valuation Measures

Market Capitalization2

23.94M

Enterprise Value

55.53M

Enterprise Value/EBITDA(ttm)

-4.36

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

1777.75%

Return on Assets(ttm)

-489.76%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-12.72M

Net Income Available to Common(ttm)

-39.22M

Diluted EPS(ttm)

-2.43

Share Statistics

Beta (5Y Monthly)

0.74

52-Week Change

96.51%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

25.30M

Dividend Yield

0.00%

Float4

25.07M

% Held by Insiders

0.90%

% Held by Institutions

22.78%

Balance Sheet

Total Cash(mrq)

3.01M

Total Cash Per Share(mrq)

0.12

Total Debt(mrq)

34.60M

Total Debt/Equity(mrq)

-62.88%

Current Ratio(mrq)

0.49%

Quick Ratio(mrq)

0.49%

Book Value Per Share(mrq)

-4.55

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.74

Free Cash Flow(ytd)

-17.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement